Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 5000221158

Medchemexpress LLC Zanzalintinib (XL092) | 2367004-54-2 | MFCD34179545 | 99.9% | 528.53 g/mol | C29H25FN4O5 | 5 MG
SDP

Catalog No. 5000221158
Encompass_Preferred

Zanzalintinib (XL092) is an orally active, ATP-competitive inhibitor of multiple receptor tyrosine kinases, supplied as a solid research-grade compound for in vitro and preclinical studies. Not for human or clinical use.

  • Orally active, ATP-competitive multi-kinase inhibitor.
  • Potent activity against MET, VEGFR2, AXL, and MER (low-nanomolar range).
  • High purity (≈99.9%) suitable for biochemical and cellular assays.
  • Available in small pack sizes for assay development and screening.
  • Solid form, stable for storage and experimental workflows.

Catalog No. 50-002-21158 Supplier Medchemexpress LLC Supplier No. HY1386965MG
May include imposed supplier surcharges.
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Zanzalintinib (XL092) is an orally active, ATP-competitive inhibitor of multiple receptor tyrosine kinases, supplied as a solid research-grade compound for in vitro and preclinical studies. Not for human or clinical use.

  • Orally active, ATP-competitive multi-kinase inhibitor.
  • Potent activity against MET, VEGFR2, AXL, and MER (low-nanomolar range).
  • High purity (≈99.9%) suitable for biochemical and cellular assays.
  • Available in small pack sizes for assay development and screening.
  • Solid form, stable for storage and experimental workflows.

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.